Retour
Fourchette du Jour
90,61 €
90,61 €
Fourchette 52 Semaines
90,61 €
90,61 €
Volume
100
Moyenne 50J / 200J
90,61 €
/
90,61 €
Clôture Précédente
90,61 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 33,0 | 0,4 |
| P/B | 7,0 | 2,9 |
| ROE % | 22,7 | 3,8 |
| Net Margin % | 18,9 | 3,9 |
| Rev Growth 5Y % | 3,5 | 10,0 |
| D/E | 0,2 | 0,2 |
Points Clés
Revenue grew 3,46% annually over 5 years — modest growth
ROE of 22,71% indicates high profitability
Net margin of 18,89% shows strong profitability
Debt/Equity of 0,22 — conservative balance sheet
Generating 120,12M in free cash flow
P/E of 33,01 — premium valuation
Croissance
Revenue Growth (5Y)
3,46%
Revenue (1Y)-2,69%
Earnings (1Y)2,56%
FCF Growth (3Y)43,83%
Qualité
Return on Equity
22,71%
ROIC16,02%
Net Margin18,89%
Op. Margin23,29%
Sécurité
Debt / Equity
0,22
Current Ratio3,14
Interest Coverage60,84
Valorisation
P/E Ratio
33,01
P/B Ratio6,98
EV/EBITDA27,06
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -2,69% | Revenue Growth (3Y) | -5,34% |
| Earnings Growth (1Y) | 2,56% | Earnings Growth (3Y) | -9,21% |
| Revenue Growth (5Y) | 3,46% | Earnings Growth (5Y) | -2,14% |
| Profitability | |||
| Revenue (TTM) | 743,20M | Net Income (TTM) | 140,39M |
| ROE | 22,71% | ROA | 14,70% |
| Gross Margin | 60,75% | Operating Margin | 23,29% |
| Net Margin | 18,89% | Free Cash Flow (TTM) | 120,12M |
| ROIC | 16,02% | FCF Growth (3Y) | 43,83% |
| Safety | |||
| Debt / Equity | 0,22 | Current Ratio | 3,14 |
| Interest Coverage | 60,84 | Dividend Yield | 0,01% |
| Valuation | |||
| P/E Ratio | 33,01 | P/B Ratio | 6,98 |
| P/S Ratio | 6,24 | PEG Ratio | 9,38 |
| EV/EBITDA | 27,06 | Dividend Yield | 0,01% |
| Market Cap | 4,63B | Enterprise Value | 4,68B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 743,20M | 763,75M | 829,51M | 817,70M | 648,68M |
| Net Income | 140,39M | 136,88M | 170,34M | 199,67M | 153,08M |
| EPS (Diluted) | 2,75 | 2,67 | 3,20 | 3,73 | 2,76 |
| Gross Profit | 451,48M | 467,71M | 483,34M | 512,43M | 379,84M |
| Operating Income | 173,08M | 179,55M | 220,25M | 255,85M | 181,39M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 955,33M | 832,02M | 799,88M | 878,70M | 732,68M |
| Total Liabilities | 276,69M | 250,48M | 256,39M | 357,32M | 261,70M |
| Shareholders' Equity | 664,17M | 572,03M | 539,39M | 520,01M | 470,98M |
| Total Debt | 146,03M | 114,41M | 65,43M | 72,14M | 73,15M |
| Cash & Equivalents | 97,94M | 27,19M | 25,32M | 124,95M | 99,04M |
| Current Assets | 569,44M | 489,61M | 509,33M | 623,07M | 506,36M |
| Current Liabilities | 181,19M | 156,65M | 199,84M | 293,89M | 190,39M |